Get started

Financials · PGEN

Precigen Inc. (PGEN) financials

For the twelve months ended Sep 30, 2026, Precigen Inc. reported $156.94M of revenue and $24.41M of net income.

Revenue, TTM
$156.94M
Net income, TTM
$24.41M
Net margin
15.6%
Free cash flow, TTM
-$74.32M
EPS, diluted, TTM
$0.07
Cash
$14.96M
Total debt
$94.26M
P/E
68.46
P/S
10.65
Market cap
$1.67B
Annual revenue$9.68M
FY2016FY2025
Annual net income-$250.64M
FY2016FY2025
Annual free cash flow-$89.83M
FY2016FY2025

PGEN revenue and earnings growth

PGEN revenueQ3 2026$74.15M

Quarter YoY
25x
QoQ
+34.9%
FY YoY
+146.7%
5Y CAGR
-21.3%
10Y CAGR
-25.1%

PGEN revenue was $74.15M in fiscal Q3 2026 (ended Sep 30, 2026), up about 25-fold from a year earlier and up 34.9% from the prior quarter. For the full fiscal 2025 it was $9.68M, up 146.7% from fiscal 2024. Compound annual growth was -21.3% over 5 years and -25.1% over 10 years. It rose in 4 of the last 10 fiscal years.

PGEN net incomeQ3 2026$35.77M

QoQ
+78.2%

PGEN net income was $35.77M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$146.34M a year earlier and up 78.2% from the prior quarter. For the full fiscal 2025 it was -$250.64M, compared with -$126.23M in fiscal 2024.

PGEN EPSQ3 2026$0.08

QoQ
+60.0%

PGEN diluted EPS was $0.08 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$1.06 a year earlier and up 60.0% from the prior quarter. For the full fiscal 2025 it was -$1.37, compared with -$0.47 in fiscal 2024.

PGEN free cash flowQ3 2026$11.45M

PGEN free cash flow was $11.45M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$29.46M a year earlier. For the full fiscal 2025 it was -$89.83M, compared with -$76.76M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$9.68M$3.92M$6.22M$26.91M$14.27M$31.99M$90.72M$151.18M$219.46M$190.93M
Cost of revenue--------$33.26M$37.71M
Gross profit--------$186.20M$153.22M
Research and development$41.33M$53.07M$48.61M----$404.59M$143.21M$112.14M
Selling, general and admin$70.13M$41.29M$40.41M----$137.81M$146.10M$142.32M
Operating income-$110.51M-$135.03M-$99.76M-----$505.61M-$137.89M-$125.17M
Interest expense$3.87M$6.0K$468.0K----$8.53M$611.0K$861.0K
Pre-tax income-$250.64M-$128.03M-$96.36M-$79.97M-$110.97M-$104.52M-$171.26M-$395.91M-$78.37M-$194.15M
Income tax$3.0K-$1.79M-$458.0K-$189.0K-$160.0K-$82.0K-$930.0K-$15.43M$2.07M-$3.88M
Net income-$250.64M-$126.23M-$95.90M$28.32M-$92.17M-$170.52M-$322.32M-$509.34M-$117.02M-$186.61M
EPS, basic-$1.37-$0.47-$0.39$0.14-$0.47-$1.02-$2.09-$3.93-$0.98-$1.58
EPS, diluted-$1.37-$0.47-$0.39$0.14-$0.47-$1.02-$2.09-$3.93-$0.98-$1.58
Diluted shares313.0M267.7M244.5M200.4M197.8M167.1M154.1M129.5M120.0M118.0M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$30.23M$29.52M$7.85M$48.60M$43.34M$52.25M$68.43M$110.18M$75.55M$69.59M
Short-term investments$67.62M$68.39M$55.28M$51.09M$72.24M$48.33M$9.26M$119.61M$6.27M$174.60M
Receivables$3.92M$926.0K$902.0K$978.0K$1.34M$16.49M$20.65M$21.18M$19.77M$21.64M
Current assets$115.23M$102.41M$68.75M$118.16M$156.63M$148.95M$234.64M$285.48M$154.05M$315.18M
Goodwill$15.23M$19.14M$26.61M$36.92M$37.55M$54.36M$54.12M$93.63M$93.75M$157.18M
Total assets$155.50M$145.27M$151.04M$215.98M$359.86M$314.59M$455.76M$716.18M$846.85M$949.07M
Current liabilities$37.31M$21.52M$22.98M$78.64M$34.65M$42.13M$122.91M$61.56M$80.17M$94.61M
Short-term debt--$0$43.22M$52.0K$360.0K$31.67M$479.0K$502.0K$386.0K
Long-term debt$93.17M$0-$0$179.88M$171.52M$186.32M$211.22M$7.54M$7.56M
Total debt$93.17M$0-$43.22M$179.93M$171.88M$217.99M$211.69M$8.04M$7.95M
Total liabilities$134.59M$78.53M$32.55M$89.72M$252.51M$247.41M$384.05M$337.45M$300.31M$379.82M
Shareholders' equity$20.91M$38.51M$118.50M$126.26M$107.35M$67.17M$71.71M$378.72M$546.54M$569.25M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow-$87.83M-$68.17M-$66.93M-$65.05M-$55.77M-$77.02M-$135.93M-$124.24M-$103.72M-$48.99M
Capital expenditures$2.00M$8.58M$1.54M$4.92M$7.25M$7.53M$37.88M$41.59M$46.67M$31.63M
Free cash flow-$89.83M-$76.76M-$68.47M-$69.97M-$63.02M-$84.55M-$173.81M-$165.83M-$150.39M-$80.62M
Investing cash flow-$1.53M-$20.71M-$3.09M$226.42M-$74.54M$27.78M$86.85M-$151.21M$104.33M-$28.39M
Financing cash flow$90.05M$110.58M$29.59M-$155.29M$121.19M$32.70M$8.14M$309.80M$4.28M$12.06M
Stock-based compensation$10.87M$9.47M$9.89M$10.21M$13.90M$18.37M$18.95M$36.30M$41.58M$42.20M
Depreciation and amortization$3.20M$4.53M$6.67M$10.77M$13.76M$17.52M$24.90M$33.11M$31.14M$24.57M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY146.7%-36.9%-76.9%88.6%-55.4%-64.7%-40.0%-31.1%14.9%10.0%
Gross margin--------84.8%80.2%
Operating margin-1141.1%-3440.2%-1602.5%-----334.4%-62.8%-65.6%
Net margin-2588.2%-3216.2%-1540.6%105.2%-646.0%-533.0%-355.3%-336.9%-53.3%-97.7%
Free cash flow margin-927.6%-1955.6%-1099.9%-260.0%-441.7%-264.3%-191.6%-109.7%-68.5%-42.2%
Return on equity-1198.6%-327.8%-80.9%22.4%-85.9%-253.8%-449.5%-134.5%-21.4%-32.8%
Return on assets-161.2%-86.9%-63.5%13.1%-25.6%-54.2%-70.7%-71.1%-13.8%-19.7%
Current ratio3.094.762.991.504.523.541.914.641.923.33
Debt to equity4.460.00-0.341.682.563.040.560.010.01

Source: XBRL data Precigen Inc. files with the SEC, latest filing dated Nov 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

PGEN peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
PGEN$156.94M-$24.41M15.6%$1.67B
LLY$86.46B+45.5%$27.58B31.9%$1.34T
JNJ$99.33B+7.8%$16.09B16.2%$682.52B
ABBV$66.01B+10.7%$10.34B15.7%$520.47B
MRK$67.38B+4.9%$2.45B3.6%$362.27B
NVS$54.53B+8.4%$13.98B25.6%$305.78B
AZN$58.74B+8.6%$10.22B17.4%$285.92B
ABT$48.23B+10.0%$4.70B9.7%$185.75B
NVODKK 309.06B+6.4%DKK 102.43B33.1%$180.00B

PGEN FAQ

8 questions
  • What is PGEN revenue?
    Precigen Inc. (PGEN) reported $156.94M of revenue for the twelve months ended Sep 30, 2026. Revenue for fiscal 2025 was $9.68M.
  • Is PGEN profitable?
    Yes. Precigen Inc. earned $24.41M in net income for the twelve months ended Sep 30, 2026, a net margin of 15.6%.
  • How much cash and debt does PGEN have?
    Precigen Inc. reported $14.96M in cash and cash equivalents and $94.26M of debt on its most recent balance sheet in SEC filings.
  • How fast is PGEN revenue growing?
    Precigen Inc.'s revenue changed +146.7% in fiscal 2025, to $9.68M. Its compound annual growth rate was -21.3% over 5 years and -25.1% over 10 years.
  • What is PGEN free cash flow?
    Precigen Inc. generated -$74.32M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of -$73.21M less capital expenditures.
  • What is PGEN earnings per share?
    Diluted earnings per share were $0.07 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did PGEN last report financial results?
    The latest statements here come from Precigen Inc.'s 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.
  • Where does this PGEN financial data come from?
    Quantisnow builds these statements from the structured XBRL data Precigen Inc. files with the SEC. It is provided for information only and is not investment advice.